Dyronib (Dasatinib (50mg))

Dyronib 50mg Tablet contains dasatinib, which is commonly used in the management of certain types of blood cancers, particularly chronic myeloid leukaemia (CML) and acute lymphoblastic leukaemia (ALL). This medication helps support patients by targeting specific cells involved in the disease, aiming to slow down or stop the progression of cancer. Its purpose is to help patients achieve better health outcomes and improve their quality of life.

Dasatinib works by inhibiting certain proteins that promote the growth and survival of cancer cells. By blocking these proteins, it may help to prevent the cells from multiplying uncontrollably, thus playing a role in controlling the condition.

For optimal results, it is important to store Dyronib at room temperature, away from moisture and heat. Consistent use as directed by a healthcare professional can contribute to better management of the condition. Patients should communicate openly with their doctor about any other medications they are taking, as well as any pre-existing health conditions.

Some common, mild side effects may include headache, fatigue, nausea, and mild skin rashes. These effects may vary among individuals, and it is essential to monitor your body’s response and inform your healthcare provider of any persistent or bothersome symptoms.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.